Core Viewpoint - The beauty industry is increasingly entering the medical aesthetics channel, with over 20 beauty brands adopting a dual beauty strategy of "medical aesthetics + beauty" to enhance their market presence and professional credibility [2][6][30]. Group 1: Market Overview - The medical aesthetics market in China is experiencing strong growth, with 18,584 compliant specialized medical aesthetics institutions reported as of January 2024 [6][7]. - The main active regions for medical aesthetics consumption are concentrated in the Pearl River Delta, Yangtze River Delta, and Chengdu-Chongqing areas [7][8]. Group 2: Industry Structure - Medical aesthetics institutions can be categorized into three types: public hospitals, large chain private hospitals, and small private hospitals and clinics [4][5]. - The development of the domestic medical aesthetics industry has gone through three main stages: initiation (1994-2000), gradual standardization (2000-2010), and rapid development (2010-present) [5]. Group 3: Brand Strategies - Many beauty companies have established significant medical aesthetics channel layouts, such as Huaxi Biological covering 7,000 medical institutions and Juzhi Biological entering approximately 1,700 public hospitals and 3,000 private hospitals and clinics [8][10]. - International beauty brands are also accelerating their medical aesthetics channel expansion, with brands like SkinCeuticals and Estée Lauder entering high-end medical aesthetics lines [10][12]. Group 4: Consumer Trends - There is a growing consumer demand for effective skincare solutions that combine beauty products with medical treatments, reflecting a trend towards the integration of lifestyle beauty and medical aesthetics [17][20]. - Consumers are increasingly seeking products with professional medical backing and comprehensive management solutions from pre-operative care to post-operative recovery [18][20]. Group 5: Challenges and Opportunities - Despite the initial success of some brands in the medical aesthetics channel, challenges remain, including product quality inconsistency and the need for effective consumer education [16][18][20]. - The dual beauty model is becoming a significant trend, with medical aesthetics companies also venturing into lifestyle beauty, leveraging their technical expertise and clinical data [22][23]. Group 6: Future Outlook - The competition in the medical aesthetics channel is expected to intensify, with beauty brands needing to establish unique advantages through solid technical research and deep medical collaboration [29][30]. - The future winners in this space will be those who can embed "professional trust" in the medical aesthetics channel and leverage "real clinical value" to gain endorsements from both doctors and consumers [30].

2 0 2 5年，美妆行业掀起一股PDRN热。 国 货 科 技 品 牌 绽 媄 娅 、 FULCYTO. ami e 等 频 发 PDRN 新 品 引 来 市 场 关 注 ； 环 亚 集 团 旗 下 幽 雅、上海家化旗下双妹等多个美妆品牌也纷纷下场；与此同时，欧莱雅集团王牌兰蔻、爱茉莉 太平洋旗下高奢品牌AP嫒彬以及LG生活健康旗下皮肤学功效性品牌CNP希恩派等一众外资美 妆也在加速布局PDRN赛道。 BEBD美修大数据显示， 目前使用PDRN的品牌达到3 8 9 4个，含有该成分的商品达1 6 9 0 1个， 且仍在快速增长。虽然PDRN与此前胶原蛋白从专业医美领域破圈至大众护肤市场的路径如出 一辙，但其蹿红的速度之快，各大品牌跟进力度之强，却是前所未有。 | 公司 | 日语 | 個選 | 环亚 | 上海家化 | 华熙生物 | | --- | --- | --- | --- | --- | --- | | 产品 | | | | | | | | 绽媒娅 | FULCYTO.amie | 幽雅 | 双妹 | 润百颜 | | | 球PDRN能量棒 | 双球PDRN超塑次抛 | DNA钠蛋白晶钻驻颜冻干套 | 油露 ...